HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$1.55
Day range
$1.46 - $1.57
Year range
$1.05 - $10.00
Market cap
47.81M USD
Avg Volume
2.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.65M | 5.65% |
Net income | -21.01M | -11.75% |
Net profit margin | — | — |
Earnings per share | -0.55 | -5.77% |
EBITDA | -22.31M | -5.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.42M | -23.88% |
Total assets | 158.58M | -31.23% |
Total liabilities | 15.55M | 7.01% |
Total equity | 143.04M | — |
Shares outstanding | 31.46M | — |
Price to book | 0.34 | — |
Return on assets | -33.81% | — |
Return on capital | -36.51% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -21.01M | -11.75% |
Cash from operations | -16.61M | -19.47% |
Cash from investing | 19.45M | 122.09% |
Cash from financing | -97.00K | -100.08% |
Net change in cash | 2.74M | -87.18% |
Free cash flow | -9.85M | -37.03% |
About
Founded
2018
Headquarters
Website
Employees
77
